BioScrip, Inc. (NASDAQ: BIOS) reported Q4 EPS of $0.12, $0.02 better than the analyst estimate of $0.10. Revenue for the quarter came in at $483.3 million versus the consensus estimate of $459.62 million.

For earnings history and earnings-related data on BioScrip, Inc. (BIOS) click here.

Earnings